KLS Keeping Law Simple Legislation in plain English

Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.

Back to Wyoming

HB0183 • 2013

Clinical trial coverage.

AN ACT relating to insurance; requiring coverage of clinical trials for cardiology; specifying applicability; and providing for an effective date.

Did Not Pass

The latest official action shows that this bill did not move forward in that session.

Sponsor
Representative Esquibel, Ken
Last action
2013-02-04
Official status
inactive
Effective date
Not listed

Plain English Breakdown

The plain English breakdown is still being put together. The official documents below are already here.

Amendments

These notes stay tied to the official amendment files and metadata from the legislature.

HB0183HS001

Standing Committee • H10

Filed

Plain English: Filed Standing Committee by H10

  • This amendment summary is using official source text because generated interpretation was skipped for this run.
  • The official amendment text was available, but an easy plain-English summary could not be produced automatically during the last sync.

Bill History

  1. 2013-02-04 House

    H Placed on General File; Did Not Consider in CoW

  2. 2013-01-31 House

    H Placed on General File

  3. 2013-01-31 House

    H10 Recommended Amend and Do Pass

  4. 2013-01-17 House

    H Introduced and Referred to H10

  5. 2013-01-16 House

    H Received for Introduction

  6. 2013-01-15 LSO

    Bill Number Assigned

Current Bill Text

Read the full stored bill text 
WORKING DRAFT
2013
STATE OF
WYOMING
13LSO-0369

HOUSE BILL
NO.

HB0183

Clinical trial coverage.

Sponsored by:
Representative(s) Esquibel, K. and Harvey and Senator(s) Esquibel, F. and Landen

A BILL

for

AN ACT relating to insurance; requiring coverage of clinical trials for cardiology; specifying applicability; and providing for an effective date.

Be It Enacted by the Legislature of the State of Wyoming:

Section 1.

W.S. 26
‑
20
‑
301(
a)(intro), (
i
), (e)(ii)(A) and (B) is amended to read:

26
‑
20
‑
301.

Clinical trials and studies coverage required.

(a)

All individual and group health insurance policies providing coverage on an expense incurred basis, individual and group service or indemnity type contracts issued by any insurer including any nonprofit corporation
and individual and group service contracts or certificates issued by a health maintenance organization which provide coverage
for treatment of cancer
or cardiovascular disease

shall
also provide coverage for routine patient care costs which a policyholder or certificate holder, or his covered dependent, receives as part of a clinical trial or study if:

(
i
)

The medical treatment is provided in a
phase II
, phase III or phase IV study or clinical trial
for the treatment of cancer
or cardiovascular disease
;

(e)

For purposes of this section:

(ii)

"Routine patient care cost" means:

(A)

A medical service or treatment that is a benefit under a health plan that would be covered if the patient were receiving standard
cancer
or cardiovascular disease
treatment; or

(B)

A drug provided to a patient during a
cancer
or cardiovascular disease
clinical trial, other than the drug that is the subject of the clinical trial, if the
drug has been approved by the federal food and drug administration for use in treating the patient's particular condition.

Section 2.

The provisions of this act shall apply to policies, contracts and certificates of insurance providing coverage to any resident of this state that are delivered, issued for delivery, continued or renewed after the effective date of this act.

Section 3.

This act is effective July 1, 2013.

(END)

1
HB0183